Loading market dashboard
Colgate-Palmolive Company
CLConsumer DefensiveNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Colgate-Palmolive Company (CL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive, a global leader in health and hygiene, today announced the launch of Serving Smiles, a new video-first podcast designed to tackle health misinformation and simplify wellness for Gen Z. Hosted by actor, singer and content creator Pressley Hosbach and award-winning advocate, actor and podcaster Madison Tevlin, the series brings expert-backed clarity to a generation overwhelmed by wellness trends and conflicting health advice that can be found on socia.
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
Some people aren't trusting this market rally, which continues to move higher. Every portfolio should have some defensive plays in it in case of a market downturn.
Consumer staples companies tend to generate resilient cash flows because their products and services remain in demand across all economic environments. The strength of Dividend Kings and long-term growers comes from structural advantages.
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant and Executive Vice President, M&A and Special Projects, John Faucher will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on Wednesday, June 3, 2026 at 8:45 am ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the web.
CL's innovation strategy is driving market share gains as premium launches, pricing and science-based products support growth across oral care and pet nutrition.
Colgate-Palmolive (NYSE:CL | CL Price Prediction) is exactly the kind of name investors hunt for when the macro picture gets murky.
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Ollie's Bargain Outlet (OLLI) and Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?
PG's U.S. Baby Care slump remains a weak spot, but strong global growth and targeted investments suggest it is a fixable issue, not a long-term drag.
Colgate-Palmolive delivered 8% sales growth in Q1 2026, but EPS declined 6%, warranting a conservative hold rating. I see organic growth of just 2.9%, with North America sales falling due to increased toothpaste competition and margin compression. FX tailwinds drove significant growth in Latin America, EMEA, and APAC, raising concerns about sustainability if currency trends reverse.
Companies like Procter & Gamble and Colgate-Palmolive have embedded themselves so deeply into daily habits that buying their products stops feeling like a decision at all. Their growth narratives are less about convincing people to switch and more about scaling trust and upgrading within it.
Colgate-Palmolive (NYSE:CL | CL Price Prediction) stock picked up a fresh price target raise from JPMorgan on Monday, May 4, with the firm lifting its target to $96 from $95 while maintaining its Overweight rating.
Colgate-Palmolive remains a Buy, supported by resilient fundamentals, an attractive and still sustainable dividend yield while they hold the Dividend King status, and prudent valuation amid macro and geopolitical headwinds. CL posted solid Q1 results, with 8.4% net sales growth, robust free cash flow, and reaffirmed 2026 sales and EPS growth guidance despite Iran-driven margin pressures. Rising input and logistics costs, driven by the Iran conflict, are expected to pressure gross margins, but CL's strong cash flows support ongoing shareholder returns.
Organic Sales Growth: Accelerated from the fourth quarter, driven by improved volume performance, particularly in Asia Pacific.Volume and Pricing Growth: Achie
CL beats Q1 earnings estimates as pricing and volume lift sales 8.4%; costs and SGPP charges weigh on margins, but outlook stays intact.
On May 1, 2026, Colgate-Palmolive Co (CL) released its 8-K filing reporting first-quarter 2026 results. Net sales rose 8.4% year over year to $5,324 million, wh
Colgate-Palmolive Company (CL) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.91 per share a year ago.
Colgate-Palmolive beat expectations for first-quarter sales and profit on Friday, helped by strong international demand for household staples such as oral and personal care products.
The maker of consumer products, including toothpaste, deodorant and soap, posted net income of $646 million, or 80 cents a share, down from $690 million, or 85 cents a share, the year prior.
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales GAAP EPS decreased 6% to $0.80; Base Business EPS* increased 7% to $0.97 GAAP Gross profit margin and Base Business Gross profit margin* decreased 20 basis points to 60.6% Net cash provided by operations was $747 million for the first three months of 2026 The Company's leadership in toothpaste continued.
Colgate-Palmolive Company (NYSE:CL) will release earnings for its first quarter before the opening bell on Friday, May 1.
Certuity LLC boosted its position in Colgate-Palmolive Company (NYSE: CL) by 106.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,628 shares of the company's stock after purchasing an additional 5,988 shares during the period. Certuity LLC's holdings in Colgate-Palmolive were
Explore the exciting world of Colgate-Palmolive (CL +1.78%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
PG's innovation-led strategy drives growth, with strong product launches, brand gains and supply chain upgrades reinforcing long-term competitive advantage.
The consumer goods giants that built empires on household staples are struggling to justify their valuations. At the time of writing, Nestlé has shed nearly a quarter of its market value over the past five years.
NEW YORK--(BUSINESS WIRE)--Due to a scheduling conflict, Colgate-Palmolive Company (NYSE:CL) will now provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:00 a.m. ET (previously 8:30 a.m. ET). The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may a.
CL eyes Q1 growth with rising sales and EPS, but cost pressures and weak volumes may limit upside despite innovation and premium push.
Brindle and Bay Financial Advisors LLC acquired a new stake in Colgate-Palmolive Company (NYSE: CL) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,347 shares of the company's stock, valued at approximately $739,000. Several other institutional investors and
AEGON ASSET MANAGEMENT UK Plc lowered its holdings in Colgate-Palmolive Company (NYSE: CL) by 24.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 651,304 shares of the company's stock after selling 214,320 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned about
These consumer staples giants are built to keep paying year after year.
Calamos Advisors LLC decreased its position in Colgate-Palmolive Company (NYSE: CL) by 5.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 289,808 shares of the company's stock after selling 16,145 shares during the quarter. Calamos Advisors LLC's holdings
Dividend Kings are outperforming SPY year-to-date, with 36 of 58 beating the index with an average gain of 7.03% versus SPY's 4.18%. Twenty-seven Dividend Kings are both potentially undervalued and offer a long-term annualized expected return of at least 10%. Recent dividend increases among Kings have been modest, with the average 2026 dividend growth rate rising to 3.11%.
Caprock Group LLC raised its stake in Colgate-Palmolive Company (NYSE: CL) by 116.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,808 shares of the company's stock after acquiring an additional 34,879 shares during the period. Caprock Group LLC's
Boston Trust Walden Corp grew its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 4.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 170,118 shares of the company's stock after purchasing an additional 7,434 shares during the quarter.
Cwm LLC grew its position in shares of Colgate-Palmolive Company (NYSE: CL) by 20.3% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 45,345 shares of the company's stock after purchasing an additional 7,665 shares during the quarter. Cwm LLC's holdings in
AE Wealth Management LLC raised its position in Colgate-Palmolive Company (NYSE: CL) by 95.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 29,633 shares of the company's stock after buying an additional 14,470 shares during the period. AE Wealth Management LLC's holdings in Colgate-Palmolive
Merit Financial Group LLC lifted its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 29.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,797 shares of the company's stock after buying an additional 10,007 shares during the period.
Asset Management One Co. Ltd. cut its position in shares of Colgate-Palmolive Company (NYSE: CL) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 388,316 shares of the company's stock after selling 33,976 shares during the
Asset Dedication LLC raised its holdings in Colgate-Palmolive Company (NYSE: CL) by 87.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,593 shares of the company's stock after acquiring an additional 7,294 shares during the quarter. Asset Dedication LLC's holdings
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, Executive Vice President, Investor Relations, Claire Ross, and Executive Vice President, M&A and Special Projects, John Faucher. Investors may access the earnings press release, prepared materials and the.
Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) reported quarterly earnings in January, placing two of consumer staples' most decorated dividend payers in sharp contrast.
Top insights from the latest market news from Monday, April 13, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
New earnings season kicks off, chip shortages hitting AI, and more
This business is already outperforming so far in 2026.
CL braces for tariff volatility into 2026, leaning on supply-chain shifts, pricing discipline and productivity gains to defend margins.
Cache Advisors LLC bought a new position in Colgate-Palmolive Company (NYSE: CL) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,621 shares of the company's stock, valued at approximately $523,000. Other hedge funds have also added to or reduced their
Allspring Global Investments Holdings LLC reduced its position in Colgate-Palmolive Company (NYSE: CL) by 62.2% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 36,331 shares of the company's stock after selling 59,762 shares during the period. Allspring Global Investments Holdings LLC's holdings in Colgate-Palmolive were
For the second-straight year and third time in five years, the Dow, S&P 500, and Nasdaq started off the calendar with quarterly losses. ‘Didn't get off the bus,' is the apt sports colloquial that comes to mind.
Revolve Wealth Partners LLC lowered its position in shares of Colgate-Palmolive Company (NYSE: CL) by 34.5% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,022 shares of the company's stock after selling 8,452 shares during the quarter. Revolve Wealth Partners LLC's
Ascent Group LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,321 shares of the company's stock after purchasing an additional 5,906 shares during the period.
Braun Stacey Associates Inc. trimmed its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 4.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,790 shares of the company's stock after selling 9,343 shares during the quarter. Braun Stacey Associates
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?
CL's Hill's Pet Nutrition outperforms a soft market as prescription diets, cat growth and science-led innovation drove share gains and sustained momentum.
Colgate-Palmolive expects to drive growth in North America this year, in part with new versions of products in oral and skin care.
Brookstone Capital Management raised its stake in Colgate-Palmolive Company (NYSE: CL) by 11.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 158,730 shares of the company's stock after purchasing an additional 15,842 shares during the period. Brookstone Capital
Colgate-Palmolive (NYSE:CL) lost a key Wall Street backer on Tuesday as TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut his price target to $85 from $96, citing surging oil-based input costs tied to the Iran War.
